BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24549051)

  • 1. Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.
    Tang M; Siddiqi A; Witt B; Yuzyuk T; Johnson B; Fraser N; Chen W; Rascon R; Yin X; Goli H; Bodamer OA; Lai K
    Eur J Hum Genet; 2014 Oct; 22(10):1172-9. PubMed ID: 24549051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
    Balakrishnan B; An D; Nguyen V; DeAntonis C; Martini PGV; Lai K
    Mol Ther; 2020 Jan; 28(1):304-312. PubMed ID: 31604675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired fertility and motor function in a zebrafish model for classic galactosemia.
    Vanoevelen JM; van Erven B; Bierau J; Huang X; Berry GT; Vos R; Coelho AI; Rubio-Gozalbo ME
    J Inherit Metab Dis; 2018 Jan; 41(1):117-127. PubMed ID: 28913702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet.
    Ning C; Reynolds R; Chen J; Yager C; Berry GT; Leslie N; Segal S
    Mol Genet Metab; 2001 Apr; 72(4):306-15. PubMed ID: 11286504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.
    Rasmussen SA; Daenzer JMI; Fridovich-Keil JL
    J Inherit Metab Dis; 2021 Jan; 44(1):272-281. PubMed ID: 32882063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia.
    Hagen-Lillevik S; Johnson J; Lai K
    J Ovarian Res; 2022 Nov; 15(1):122. PubMed ID: 36414970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic basis of classical galactosaemia in Polish patients.
    Jezela-Stanek A; Bauer A; Wertheim-Tysarowska K; Bal J; Rygiel AM; Sykut-Cegielska J
    Orphanet J Rare Dis; 2021 May; 16(1):239. PubMed ID: 34030713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase.
    Riehman K; Crews C; Fridovich-Keil JL
    J Biol Chem; 2001 Apr; 276(14):10634-40. PubMed ID: 11152465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and functional studies reveal a novel noncoding variant in GALT associated with a false positive newborn screening result for galactosemia.
    Liu Y; Sidhu A; Bean LH; Conway RL; Fridovich-Keil JL
    Clin Chim Acta; 2015 Jun; 446():171-4. PubMed ID: 25920691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated expression of galactose-1-phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts.
    Brophy ML; Stansfield JC; Ahn Y; Cheng SH; Murphy JE; Bell RD
    J Inherit Metab Dis; 2022 May; 45(3):481-492. PubMed ID: 34918784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosemia: when is it a newborn screening emergency?
    Berry GT
    Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactose-1 phosphate uridylyltransferase (GalT) gene: A novel positive regulator of the PI3K/Akt signaling pathway in mouse fibroblasts.
    Balakrishnan B; Chen W; Tang M; Huang X; Cakici DD; Siddiqi A; Berry G; Lai K
    Biochem Biophys Res Commun; 2016 Jan; 470(1):205-212. PubMed ID: 26773505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A yeast expression system for human galactose-1-phosphate uridylyltransferase.
    Fridovich-Keil JL; Jinks-Robertson S
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):398-402. PubMed ID: 8421669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic Galactosemia: Clinical and Computational Characterization of a Novel
    Forte G; Buonadonna AL; Pantaleo A; Fasano C; Capodiferro D; Grossi V; Sanese P; Cariola F; De Marco K; Lepore Signorile M; Manghisi A; Guglielmi AF; Simonetti S; Laforgia N; Disciglio V; Simone C
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model.
    Slepak T; Tang M; Addo F; Lai K
    Mol Genet Metab; 2005 Nov; 86(3):360-71. PubMed ID: 16169270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous occurrence of various mutations and polymorphisms in cis and in trans of the galactose-1-phosphate uridyltransferase gene in a Turkish family with classical galactosemia.
    Schuster V; Podskarbi T; Ottensmeier H; Haubner M; Shin YS
    J Mol Med (Berl); 1998 Sep; 76(10):715-9. PubMed ID: 9766850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splicing mutation in GALT gene causing Galactosemia in Ecuadorian family.
    De Lucca M; Barba C; Casique L
    Clin Chim Acta; 2017 Jul; 470():20-23. PubMed ID: 28450132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia.
    Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL
    J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal.
    Coelho AI; Ramos R; Gaspar A; Costa C; Oliveira A; Diogo L; Garcia P; Paiva S; Martins E; Teles EL; Rodrigues E; Cardoso MT; Ferreira E; Sequeira S; Leite M; Silva MJ; de Almeida IT; Vicente JB; Rivera I
    J Inherit Metab Dis; 2014 Jan; 37(1):43-52. PubMed ID: 23749220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multinational study of acute and long-term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT.
    Katler QS; Stepien KM; Paull N; Patel S; Adams M; Balci MC; Berry GT; Bosch AM; DeLaO A; Demirbas D; Edman J; Ficicioglu C; Goff M; Hacker S; Knerr I; Lancaster K; Li H; Mendelsohn BA; Nichols B; de Rezende Pinto WBV; Rocha JC; Rubio-Gozalbo ME; Saad-Naguib M; Scholl-Buergi S; Searcy S; de Souza PVS; Wittenauer A; Fridovich-Keil JL
    J Inherit Metab Dis; 2022 Nov; 45(6):1106-1117. PubMed ID: 36093991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.